Heiss C, Schnettler R
Klinik und Poliklinik für Unfallchirurgie, Justus-Liebig-Universität Giessen.
Unfallchirurg. 2005 May;108(5):348-55. doi: 10.1007/s00113-005-0951-y.
Bone adhesives are degraded to non-toxic products and resorbed after fulfilling their function in contact with living tissue. There has been a growing interest in the use of such adhesives in all fields of medicine in recent years. The wish of trauma surgeons and orthopaedic for alternatives to osteosynthesis is reflected in the development of a variety of surrogates of biological or synthetic origin. Despite a longstanding history of research in this field, a clinically applicable alternative in the field of bone gluing has not yet been found. This application has consistently failed because these adhesives were not tailored to the conditions met within the living organism. The following article is meant to provide an overview of the development, the state of the art, and today's knowledge of bone adhesives. In addition, it points out the tremendous progress in this area, made possible by the joint efforts of basic researchers and surgeons. The results of this collaboration show that in the future a successful reconstructive surgery using synthetic biomaterials will become feasible.
骨粘合剂在与活组织接触并完成其功能后会降解为无毒产物并被吸收。近年来,在医学的各个领域对使用此类粘合剂的兴趣日益浓厚。创伤外科医生和骨科医生对骨接合替代方法的期望反映在各种生物或合成来源替代物的开发中。尽管该领域有着悠久的研究历史,但尚未找到骨粘合领域临床适用的替代方法。这种应用一直未能成功,因为这些粘合剂并非针对活体内的条件量身定制。以下文章旨在概述骨粘合剂的发展、现状以及当今的相关知识。此外,它还指出了基础研究人员和外科医生的共同努力在该领域取得的巨大进展。这种合作的结果表明,未来使用合成生物材料进行成功的重建手术将变得可行。